Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.


Journal

Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645

Informations de publication

Date de publication:
02 2020
Historique:
received: 02 05 2019
revised: 11 09 2019
accepted: 27 09 2019
pubmed: 9 10 2019
medline: 7 4 2021
entrez: 10 10 2019
Statut: ppublish

Résumé

To investigate the effect of hypoglycaemia on platelet and coagulation activation in people with type 2 diabetes. This monocentric, open, single-arm, mechanistic trial included 14 people with established type 2 diabetes (four women, 10 men, age 55 ± 7 years, glycated haemoglobin concentration 51 ± 7 mmol/mol) receiving metformin monotherapy. A stepwise hyperinsulinaemic-hypoglycaemic clamp experiment (3.5 and 2.5 mmol/L, for 30 minutes respectively) was performed, aiming to investigate platelet and coagulation activity during predefined plateaus of hypoglycaemia, as well as 1 day and 7 days later. While platelet activation assessed by light transmittance aggregometry did not significantly increase after the hypoglycaemic clamp procedure, the more sensitive flow cytometry-based measurement of platelet surface activation markers showed hypoglycaemia-induced activation 24 hours (PAC1 A single event of insulin-induced hypoglycaemia led to an increase in markers of platelet activation and coagulation in people with early stages of type 2 diabetes on metformin therapy. However, the activation occurred with a delay and was evident 24 hours and 7 days after the actual hypoglycaemic episode.

Identifiants

pubmed: 31595635
doi: 10.1111/dom.13889
pmc: PMC6972619
doi:

Substances chimiques

Biomarkers 0
Metformin 9100L32L2N

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-221

Subventions

Organisme : Investigator Initiated Studies Program of Merck Sharp & Dohme Corp
Pays : International

Informations de copyright

© 2019 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

Références

J Immunol. 2001 Apr 1;166(7):4341-7
pubmed: 11254687
Diabet Med. 2016 Feb;33(2):224-30
pubmed: 26043186
Diabetes Metab. 2018 Nov;44(5):431-436
pubmed: 29784564
Diabetes Care. 2018 Dec;41(12):2625-2633
pubmed: 30327358
Thromb Haemost. 2018 Jul;118(7):1305-1315
pubmed: 29890521
Diabetes Care. 2015 Jan;38(1):22-8
pubmed: 25352653
N Engl J Med. 2008 Jun 12;358(24):2545-59
pubmed: 18539917
Lancet. 1998 Sep 12;352(9131):854-65
pubmed: 9742977
Thromb Res. 2016 Apr;140:30-35
pubmed: 26896607
J Biol Chem. 1985 Sep 15;260(20):11107-14
pubmed: 2411729
J Clin Endocrinol Metab. 2012 Jan;97(1):41-8
pubmed: 22049171
Diabetes Obes Metab. 2000 Apr;2(2):75-82
pubmed: 11220527
Diabetes Care. 2010 Jul;33(7):1529-35
pubmed: 20587723
Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):353-63
pubmed: 18461635
Platelets. 2011;22(6):461-5
pubmed: 21668292
BMJ. 2010 Jan 08;340:b4909
pubmed: 20061358
Lancet. 1998 Sep 12;352(9131):837-53
pubmed: 9742976
Diabetes Care. 2012 Feb;35(2):409-14
pubmed: 22179956
Diabetes. 1986 Jul;35(7):818-25
pubmed: 2941327
Thromb Haemost. 1982 Jun 28;47(3):254-8
pubmed: 7051410
Diabetes Care. 2010 Jul;33(7):1591-7
pubmed: 20587725
Metabolism. 2009 Apr;58(4):443-8
pubmed: 19303962
Diabetes. 2012 Sep;61(9):2380-4
pubmed: 22688337
J Thromb Haemost. 2017 Dec;15(12):2443-2450
pubmed: 29028283
Front Physiol. 2018 Oct 12;9:1236
pubmed: 30405423
Diabetes Care. 2009 Nov;32 Suppl 2:S357-61
pubmed: 19875581
Diabetes. 1982 Jul;31(7):615-7
pubmed: 6761199
ESC Heart Fail. 2018 Aug;5(4):603-609
pubmed: 29524314
Circulation. 2009 Dec 22;120(25):2577-85
pubmed: 19923168
Expert Rev Endocrinol Metab. 2017;12(1):21-33
pubmed: 29109754
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
N Engl J Med. 2009 Jan 8;360(2):129-39
pubmed: 19092145
Diabetes Obes Metab. 2020 Feb;22(2):212-221
pubmed: 31595635
Diabetes Care. 2010 Jul;33(7):1686-7
pubmed: 20587729
Diabetologia. 2018 Jan;61(1):58-65
pubmed: 28913543
Immunol Res. 2011 May;50(1):10-21
pubmed: 21203905
N Engl J Med. 2017 Aug 24;377(8):723-732
pubmed: 28605603
Diabetes. 2015 Jul;64(7):2571-80
pubmed: 25695946

Auteurs

Felix Aberer (F)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Peter N Pferschy (PN)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
CBmed GmbH, Centre for Biomarker Research in Medicine, Graz, Austria.

Norbert J Tripolt (NJ)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Caren Sourij (C)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Anna M Obermayer (AM)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
CBmed GmbH, Centre for Biomarker Research in Medicine, Graz, Austria.

Florian Prüller (F)

Medical University of Graz, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria.

Eva Novak (E)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Philipp Reitbauer (P)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Harald Kojzar (H)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
CBmed GmbH, Centre for Biomarker Research in Medicine, Graz, Austria.

Barbara Prietl (B)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
CBmed GmbH, Centre for Biomarker Research in Medicine, Graz, Austria.

Selina Kofler (S)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
CBmed GmbH, Centre for Biomarker Research in Medicine, Graz, Austria.

Martina Brunner (M)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Eva Svehlikova (E)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Tatjana Stojakovic (T)

Medical University of Graz, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria.

Hubert Scharnagl (H)

Medical University of Graz, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria.

Abderrahim Oulhaj (A)

College of Medicine and Health Sciences, United Arab Emirates University, Institute of Public Health, Al Ain, UAE.

Faisal Aziz (F)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
CBmed GmbH, Centre for Biomarker Research in Medicine, Graz, Austria.

Regina Riedl (R)

Medical University of Graz, Institute for Medical Informatics, Statistics and Documentation, Graz, Austria.

Harald Sourij (H)

Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH